Skip to main content
Signal8

Knight Therapeutics Inc.

SEC insider (Form 3/4/5 filer). CIK 0001756235. 10% Owner at 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 11, 2025. Located in MONTREAL.

Companies Knight Therapeutics Inc. has filed insider reports for

  • 60 DEGREES PHARMACEUTICALS, INC. (SXTP): 10% Owner
  • Synergy CHC Corp. (SNYR): 10% Owner
Knight Therapeutics Inc. profile photo

Knight Therapeutics Inc.

CIK: 0001756235

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

60 DEGREES PHARMACEUTICALS, INC. logo
SXTP

60 DEGREES PHARMACEUTICALS, INC.

10% Owner
Synergy CHC Corp. logo
SNYR

Synergy CHC Corp.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Synergy CHC Corp. logo
    SYNR

    Synergy CHC Corp.

    Jun 11, 2025
    Purchase

    Pre-Funded Common Stock Purchase Warrant

    Indirect
    428.6K shares-

1-1 of 1